Chinese vice commerce minister said Monday that Beijing would like the U.S. to cancel "inappropriate" actions against Chinese companies.China Economyread more
Sixteen Asia Pacific countries have been negotiating the Regional Comprehensive Economic Partnership since 2013, with India's reluctance to open up its markets a major...Asia Economyread more
The secretary of State said he was traveling to Saudi Arabia and the United Arab Emirates to make sure that the U.S. is "strategically aligned" with its allies.Politicsread more
Experts say Facebook's cryptocurrency project Libra has been a catalyst for the price of bitcoin going higher.Technologyread more
Goldman Sachs helped state firm 1MDB to raise $6.5 billion in 2012 and 2013, and collected higher-than-typical fees of $600 million for the deals.Financeread more
Value investing has become increasingly irrelevant thanks to central banks and technology, according to AB Bernstein.Investingread more
Indonesian Trade Minister Enggartiasto Lukita said all 16 countries negotiating a mega Asia-Pacific trade agreement should remain in the framework.World Economyread more
Stocks in Asia Pacific traded mixed on Monday afternoon, while oil prices continued to rise as tensions between the U.S. and Iran lingered after the latter shot down an...Asia Marketsread more
His comments come after a series of rapid escalations between Washington and Tehran.World Politicsread more
The U.S. is provoking Iran and growing risks of miscalculation could lead to a "world war," according to Malaysia's Prime Minister Mahathir Mohamad.World Politicsread more
Trump's comments come after he called off strikes against the Islamic Republic this week over concerns that a military response would kill scores of people.Politicsread more
Amazon will not use pharmacy licenses it obtained from Tennessee and Indiana to sell prescriptions, but will use them to sell medical devices and supplies instead, the company has told regulators.
Analysts from the investment firm Jefferies uncovered correspondence between the company and regulators in Tennessee and Indiana. Excerpts from these documents, which Jefferies obtained in a Freedom of Information Act request, show that Amazon intends to sell medical devices and supplies in its Indiana fulfillment center, but would not be storing or distributing prescription drugs.
"Applicant (Amazon) will not store or ship drugs," the application clearly states.
That said, most industry experts aren't ruling out the possibility of Amazon entering the prescription drug market. Instead, they maintain that it's a matter of if, not when.
"There has been a massive overreaction to the Amazon threat," said Adam Fein, president of Pembroke Consulting and a drug supply chain expert, to CNBC.
"I would never underestimate Amazon," he continued. "But I remain somewhat skeptical of Amazon's ability and desire to fundamentally alter the drug channel (as) the incumbents will have many opportunities to defend their position, capture value from internet technologies, and streamline distribution."
Jefferies analysts stress that Amazon could navigate the complexities of the prescription drug space, but that it will be likely to disrupt some lower-hanging fruit first. And that includes selling medical supplies, such as surgical equipment and devices. That would be a more immediate threat to medical distribution companies, like McKesson and Cardinal Health, rather than to pharmacies and pharmacy benefits managers.
Amazon is expected to make a decision about whether it will get into the prescription drug business in the coming weeks.